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The paper was written due to interest in the presentation of urinary tract 
infections in children. I had little knowledge of the subject before I started the 
study, but I was always interested in paediatrics and keen to learn more such a 
common disease. The objective of the study was to register the presentation of 
urinary tract infections, their risk factors, the blood and urinary samples and see 
what treatment they received. The thesis question was shaped in collaboration 
with Claus Klingenberg, whom I knew beforehand as a lecturer, and was 
continuously worked upon. 
The data collection, plotting and analyzation was performed by me with 
guidance from Claus. 
A big thanks goes to the my counsellor Claus Klingenberg for guidance, 
teaching, supporting and discussing my paper, providing the necessary changes. 
 
 






Background and objective: Urinary tract infections (UTI) are common in children and can 
be hard to diagnose early. They range from benign to life threatening conditions, sometimes 
requiring prompt treatment. The objective of this paper is to register the basic information and 
the signs, symptoms and risk factors of children with UTIs, what diagnostics were performed, 
their results and what treatment and follow-up they were given. 
Material and methods: A retrospective study was conducted using data available from the 
University Hospital of North Norway (UNN) departments of Tromsø, Harstad and Narvik. 
The data was collected in the summer of 2017, going through medical records from 
01.01.2007-31.12.2016. The relevant data related to the paper was anonymized and 
subsequently categorized in an SPSS file. The study was approved as a quality study by the 
representative of the Institutional review Board (Personvernombudet) at UNN, Per Bruvold. 
Results: Of 396 patients in the hospital’s records, 133 had a confirmed febrile urinary tract 
infection. Mean age was 3.3 years, 68.4% of the patients were female. The single most 
common presenting symptom was fever 45/133 (33.8%), especially in children <2 years of 
age where it was 35/82 (42.7%). The prevalence of any structural genitourinary abnormality 
was 57/133 (42.9%). Of 125 urine samples cultured, 97/125 (72.9%) were positive. E.coli was 
the most common pathogen 74/97 (76.3%). Blood culture was sampled in 109/133 (82.0%), 
the prevalence of bacteremia was 11/109 (10.1%).  
Conclusion: This study has shown that the gender and age distribution was in accordance to 
available literature. Dipstick analyses were performed in 97.7% and the urine cultured in 
94.0% of the cases. The signs, symptoms and risk factors differed significantly (P<0.05) 
based on the factors of age, gender, pathogens and CRP-values. Risk factors were associated 
with higher age, male gender, non-E.coli and higher CRP-values. There were 72.9% cases of 
significant bacteruria and 10.2% cases of significant bacteremia. E.coli was the most 
prevalent pathogen found, representing 76.3 % of urine isolates and 63.6% of the blood 
cultures. Ultrasound was performed in 110 patients and MCUG in only 18. Abnormal 
genitourinal findings had a prevalence of 57/133 (42.9%), and VUR was found in 15/133 
(11.3%). Antibiotics were given to 131/133 (98.5%) of the patients, of which empirical 
treatment followed Norwegian guideline standards in 114/126 (90.5%) of the cases. 
Ampicillin-Gentamicin IV was the most commonly used antibiotic in both the empirical 





The idea to this thesis came from Claus Klingenberg, my supervisor. I had little prior 
knowledge about febrile urinary tract infections in children and subsequently thought it a 
brilliant idea to boost my knowledge.  
Claus Klingenberg is a professor at the institute of clinical medicine and a physician at the 
paediatric ward at UNN Tromsø. He is the lead author of the current acute paediatric 
guidelines about urinary tract infections in Norway (1) and has held lectures about it for years, 
including for my class. He therefore had a wish of mapping out the typical patient and see 
what the current practices at the hospital were.  
Before I started working on this thesis I had limited knowledge about urinary tract infections 
other than dipsticks and painful, frequent voiding. I have learned a lot more about the typical 
patient, how he or she presents and what background they often have. 
 
Theoretical background 
ICD-10 defines urinary tract infection (UTI) as “a bacterial infectious process affecting any 
part of the urinary tract, most commonly the bladder and the urethra. Symptoms include 
urinary urgency and frequency, burning sensation during urination, lower abdominal 
discomfort, and cloudy urine” (2). It is further divided into lower (cystitis) and upper 
(pyelonephritis) UTI. Cystitis is less common than pyelonephritis in children below 2 years of 
age (3), whereas in adults cystitis is much more common than pyelonephritis (4).  
UTI is a common disease in children. At the age of 8 years, 7-8% of all girls and 2% 
of all boys have experienced at least one episode of UTI (5). Around 7.0% of children below 
2 years of age presenting with fever are reported to have a UTI. In the US it is reported that 
girls, infants <1 years of age, white children and uncircumcised children are at greatest risk of 
having UTI (6).  
 
Renal scarring and risk factors 
Renal scarring is one of the feared consequences of upper UTI. A meta-analysis including 
1280 children and adolescents from 0-18 years of age with a first episode of UTI found renal 
scarring in 15.5%, of which 50.3 % had vesicoureteric reflux (VUR) (7). 
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General risk factors associated with increased risk for developing scarring are 
recurrent febrile UTIs, delay in treatment, bladder and bowel dysfunction, obstructive 
malformations and VUR (8). Urostasis is a good culture medium for uropathogens (8), hence 
obstructive urological diseases increase the risk of UTIs. Two predisposing risk factors for 
UTIs are VUR and bowel and bladder disorder.  
VUR is a retrograde passage of urine from the bladder into the upper urinary tract and 
occurs in nearly 1% of all neonates (9). In its primary form, it results from incomplete closure 
of the ureterovesical junction during contraction of the bladder. It is diagnosed through 
micturating cystourethrogram (MCUG)(10). VUR is graded from I-V, depending on the 
severity of the reflux, with dilation of the upper tract in grade III-V (Figure 1). VUR is also 
associated with renal scarring, and the risk increases with each grade of VUR (7).  
Bladder and bowel dysfunction is a disorder of variable pathophysiology, but in 
general it is characterized by dysfunction of the pelvic muscles, bladder and/or the sphincter 
(8). The prevalence of bladder and bowel dysfunction is estimated to be 15% in children, but 
symptoms of it are reported in up to 40% of toilet trained children with their first UTI and 
80% in children with recurrent (3 or more) UTIs (8).  Strong predictors for development of 
renal scarring were VUR, (especially higher grades IV-V), abnormal renal bladder 
ultrasonography, inflammatory markers including CRP > 40 mg/L or a polymorphonuclear 
cell count >60%, temperature ≥39 °C or a causative uropathogen other than Escherichia coli 
(E. coli).  
The long-term consequences of renal scarring caused by UTIs are not clearly 
understood. A Finnish study from 2011 reported that among 366 patients with chronic kidney 
disease (CKD) there was only one-1 case in which recurrent UTIs seemed to be the cause of 
CKD (11). In a Swedish study from 1995 where they followed 111 high-risk girls from their 
first UTI in childhood until median 15 years later, 7 out of 54 with renal scarring developed 
decreased glomerular filtration rate, all of whom had VUR. No one developed end-stage renal 
disease (ESRD) (12). The limited evidence of long-term sequelae in those with renal scarring 
associated with UTI, has led some to doubt the effectiveness of aggressive treatment of it 
(13). Moreover, diagnosis of renal scarring is by scintigraphy, and it is challenging to 
differentiate between congenital dysplasia and scarring. This means that some cases coined as 
scarring may have been congenital and non-preventable. 
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Signs and symptoms 
The primary and sometimes only symptom of UTI in children younger than 2 years of age is 
fever (14).  In a study conducted from 1976 through 1981, 63 out of 100 children aged 5 days 
to 8 months with clinical signs and features of UTI, were brought to medical attention 
because of fever (15). For neonates, some of the recorded numbers for fever as the main 
symptom have been 32/80 (40%) (16) and 11/64 (17%) (17). In other instances, vomiting 
(16/43), jaundice (16/43) and failure to thrive (13/43) were more prominent features than 
fever (9/43), with poor feeding and loose stools/diarrhoea being more seldom (17, 18). In a 
meta-analysis of studies including children with UTI (19) a history of previous UTI 
(Likelihood ratio (LR) 2.3-2.9) and fever > 40oC (LR 3.2-33) were the two most helpful signs 
in identifying UTI in children below 2 years of age. Older children present also with fever, 
symptoms of the lower urinary tract and abdominal pain. Flank pain, chills and fever is 
suggestive of pyelonephritis (14). Abdominal pain (LR 6.3), back pain (LR 3.6), frequency 
and/or dysuria (LR 2.2-2.8) and new-onset urinary incontinence (LR 4.6) were the most 
useful signs in predicting UTIs in verbal children (19). In the case of acute cystitis, children 
typically present with absence of fever and symptoms from the lower urinary tract, which 
includes dysuria, frequency, urge, new-onset urinary incontinence, suprapubic/abdominal pain 
and/or haematuria (20). 
 
Diagnostics 
According to the Norwegian guidelines, which came into effect in 1998 and were revised in 
2013 (1), the diagnosis of UTI requires clinical symptoms, pyuria and significant 
bacteriuria. The clinical examination focus on possible foci of infection. In a child with fever 
and no obvious focus (e.g from the respiratory tract) UTI should always be suspected. The 
guidelines recommend that highly febrile children, or those with poor appearance, should 
receive the same examination as if you suspect possible sepsis. That includes checking for 
cleared airways, respiration rate, oxygen saturation, pulse, capillary filling time, blood 
pressure, mental state (awareness and reaction), diuresis, and looking for a focus by checking 
clinical signs by organ.  
According to the National Institute for Health and Care Excellence (NICE) the history 
taking and clinical examination should focus on the following risk factors for UTI; poor urine 
flow, history suggesting previous UTI or confirmed previous UTI, recurrent fever of uncertain 
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origin, antenatally-diagnosed renal abnormality, family history of VUR or renal disease, 
constipation, dysfunctional voiding, enlarged bladder, abdominal mass, evidence of spinal 
lesion, poor growth and high blood pressure (21). The clinical examination should focus on 
the urogenital area in regards to lesions, phimosis and/or urethral meatal stenosis in boys and 
labial adhesion in girls (1).  
 
Urine sampling and analyses 
The Norwegian guidelines recommend midstream urine in children capable of doing so. A 
clean catch sample taken during spontaneous voiding when a small child is undressed is a 
good alternative. Urine bag collection is often used in the youngest children, but has 
limitations due to possible contamination leading to high risk of false positive results (22). 
Preferably, two bag collections should be performed and if both include the same single 
species of uropathologic bacteria these can often be trusted. Urine samples obtained by 
catheterization and suprapubic aspiration (SPA) are less commonly contaminated and thus of 
higher quality, but more invasive, especially SPA.  
The urine is often analysed with dipstick, microscopy and culture. The advantages of 
dipstick is that they are convenient and inexpensive, and little dependent on operator skills. 
The leukocyte esterase (LE) and nitrite tests are performed, the tests having a sensitivity of 
84% and 50% and a specificity of 78% and 98%, respectively (23). Urine microscopy is 
dependent on operator skill (24). At UNN, they use a centrifuged sample (25), where one 
searches for leukocytes, cylinders and bacteria (1). For culture, the sample should be sent for 
analysis soon or be cooled down. Bacteriuria is defined as >10.000 CFU/ml, but lower 
numbers do not rule out UTI as the urine in children remains in the bladder for a shorter time 
and thus carries less bacteria. More than one species found in urine culture is likely to be a 
contamination. Finally, any culture result needs to be interpreted in conjunction with the 
clinical picture and the dipstick and/or microscopy results. 
 
Microbiology 
The most common pathogen causing UTI in children is E. coli, which accounted for 79% of 
urinary isolates in an American study (26). The same study found great differences in males 
and females, with E. coli accounting for 50% and 83% of UTI cases, respectively. The next 
most common pathogens among males were Enterococcus spp. (17%), Proteus mirabilis 
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(11%) and Klebsiella spp. (10%). In a Norwegian study from 2001 (27), E. coli accounted for 
56.7% of inpatient and 68.3% of outpatient UTI cases. The differences between the American 
and the Norwegian outpatient numbers could possibly be explained by the lack of culture 
performed in uncomplicated UTIs in women (28). Coagulase negative staphylococci and 
enterococci were significantly more likely to occur in urine samples from inpatients (12.5% 
and 7.9%) than in those obtained from outpatients (7.5% and 4.7%).  
Antibiotic resistance rates for E. coli in urine cultures (Table 1) in Norway is 34.1% 
for ampicillin and 23% for trimethoprim, whilst the resistance rates for other antibiotics were 
generally lower. For Klebsiella spp. in urine cultures (Table 2), the overall antibiotic 
resistance is generally lower than for those seen in E. coli. For Enterococcus spp. in urine 
cultures (Table 3), it showed a 5.4% resistance towards ampicillin and 15.8% towards 
gentamicin (29). Proteus mirabilis in Norway is susceptible to most antibiotics, except for 
innate resistance towards nitrofurantoin and a 25% resistance rates to trimethoprim (30, 31). 
 
Imaging 
The Norwegian guidelines, based on the NICE guidelines, for imaging of children with their 
first episode of febrile UTI have age dependent criteria. For children below 3 years of age, a 
renal and bladder ultrasonography (RBUS) should be performed within 3 days if < 3 months 
of age and/or other risk factors are present. These risk factors are; age < 6 months of age, 
urosepsis, inadequate response to treatment within 48 hours, hydronephrosis on prenatal 
ultrasound, recurrent upper UTIs, pathogen other than E. coli, older boys, elevated s-
creatinine and elevated blood pressure.  Otherwise, a RBUS should be performed within 4-6 
weeks.  
The indications for MCUG in children below 3 years of age are based on ultrasound 
and clinical findings/evidence. If the ultrasound is normal, MCUG should be performed in 
girls with risk factors, the same as the ones listed above, or in infants with a primary UTI 
before 3 months of age. If the ultrasound is pathological/indicating a VUR, an MCUG should 
be performed. Pathologies include dilation of the renal pelvis, calyces and/or ureters, in 
addition to a big bladder or small kidneys. MCUG could be used in the case of recurrent 
UTIs.  
In children older than 3 years of age, RBUS should be performed after the first 





The Norwegian guidelines for antibiotics usage (1) differentiate between acute pyelonephritis 
and cystitis. The recommended treatment plans are 7-10 and 3-5 days, respectively. Initial 
intravenous (IV) treatment is recommended if the patient; is <2 months of age (liberally until 
6 months), in very ill patients, if nauseated/vomiting and/or has any known renal-urinary 
anomaly. Empirical first choice IV treatment for acute pyelonephritis is ampicillin 50 mg/kg x 
3-4 and gentamicin 7 mg/kg x 1, which covers Gram-negatives and enterococci. 
Alternatively, one can use ceftriaxon 50–75 mg/kg x 1, which covers Gram-negatives very 
well, but not enterococci.  
Treatment should not be initiated before adequate urine samples have been obtained. 
Treatment is to be adjusted depending on culture and susceptibility tests. If the patient 
becomes clinically stabile, the medicine can be given orally. Empirical first choice peroral 
(PO) treatment is pivmecillinam (15 mg/kg x 3). Amoxicillin-clavulanic acid mixture (15–20 
mg/kg x 3) is an option, but currently still needs to be imported from abroad if needed. 
Cephalexin in mixture or as tablets (12.5-25 mg/kg x 4) is another option, though it is not 
optimally suited for Gram-negative coverage. For cystitis PO trimethoprim (3 mg/kg x 2), 
nitrofurantoin (1.5 mg/kg x 2) or pivmecillinam (7.5 mg/kg x 3) are recommended. 
 
Objectives of this thesis 
The objective of this master thesis was to study clinical symptoms, diagnostics tests used, 
therapy and outcome of children with febrile UTI (pyelonephritis) admitted to the hospital.  
The following topics were investigated in a thorough retrospective study: 
1. Gender and age 
2. Signs, symptoms and risk factor frequencies 
3. What imaging was performed? 
o Which were used and what did the results show? 
4. Urine results? 
o Dipsticks, how many were performed and what did they show? 
o What was the pathogen  
5. Blood results? 
o What did the most relevant lab values show? 
o Blood culture, which pathogens were seen? 
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6. Antibiotic treatment 
o What did they receive? 
o How did they receive it?  
 
 
Material and methods 
The project was planned and shaped in October 2016. In meetings with Claus Klingenberg 
(Department of Paediatrics at UNN) we decided on a thesis statement and for him to act as 




In this thesis the terms “febrile urinary tract infection” and pyelonephritis were seen as 
equivalent. We defined them as having a temperature above 38 °C and having a urinary 
dipstick ≥ 2+ leucocytes or another certain diagnosis of UTI based on clinical symptoms, 
pyuria and bacteriology. 
 
Study design and search criteria 
We conducted a retrospective cohort study by reviewing medical records. The study 
population were children admitted to UNN’s three hospitals, Tromsø, Harstad and Narvik 
with a confirmed diagnosis of pyelonephritis. Children with diagnoses of cystitis or 
pyelonephritis without confirmed culture, significant dipstick or radiological evidence were 
excluded from the study.  
We identified the possible cases of UTI by searching the patient administrative system 
for all children (0-15 years) diagnosed with UTI according to the International Classification 
of Diseases, 10th revision (ICD-10) and admitted to the Paediatric Department UNN during 
the study period 01.01.2007 - 31.12.2016. The diagnosis-codes included were N10, N39.0, 
N11.0, N11.8, N11.9 and N12.  
8 
 
The data was collected over a 2-month period in June and August of 2017 from a computer 
connected to UNN’s patient record system, DIPS. The children’s medical records were 
reviewed. 
The included patients were 0-15 years of age, admitted to the hospital and discharged 
with a confirmed diagnosis of pyelonephritis. The children excluded were either non-febrile, 
had uncertain urine findings or were treated as an outpatient.  
The categorization of the data was made on the basis of gender, age, signs and 
symptoms, diagnostic modalities, microbes and findings, including predisposing conditions, 
and antibiotic treatment.  
 
Statistics 
The statistics program SPSS v. 25 was used. Data are presented using descriptive analyses 
with frequency tables, means, median and range. Comparisons of two groups were done by 
using t-tests (continuous data) and chi-square tests (categorical data). Age was dichotomized 
into children younger or older than 2 years, reflecting their verbal ability (32). Urine culture 
findings were dichotomized into E. coli and non-E. coli. CRP values were dichotomized into 
below or higher than 100 mg/l. Temperature was dichotomized into below 40oC, and 40oC 
and above as some literature suggests (33). 
 
When collecting the antibiotic resistance data, intermediary resistant microbes were classified 
as sensitive as many intermediate resistant microbes are sensitive to antibiotics in UTIs.  
“Known VUR” includes every case of VUR. From previously diagnosed, diagnosed while 
admitted or after discharge, they were all categorized as the same. 
The cases selected for the risk stratification were the following: Age < 6 months or if <3 years 
old and urosepsis, recurrent upper UTIs, pathogen other than E.coli, boys 2 years and older, 
or elevated s-creatinine.  
The reference creatinine values were gathered from UNN’s “Laboratoriehåndbok” for 
each age group. 
 
Variables 




The literature was mainly gathered through articles used in meta-analyses, but also from 
searching NCBI with MESH searches through a period of October 2016 to June 2018. 
The searches included: 
- Urinary tract infection + Children 
- Urinary tract infection + Children + sepsis. 
- Pyelonephritis + children 
Pyelonephritis + children + sepsis 
References were managed using Endnote x8 
 
Ethics 
The study was approved as a quality study by the representative of the Institutional review 
Board (Personvernombudet) at UNN, Per Bruvold. They concluded that the handling of 
persondata would be regulated by § 7-12 in “Personopplysningsforskriften” and authorized by 
“Helsepersonelloven” § 26.   A more detailed description of the complete certificate of 






A total of 396 children were registered with the ICD-10 diagnoses that were searched for. 
Most of them were not included as they were treated as outpatients. Others were excluded 
because of uncertain UTI-diagnoses. Some patient data were missing due to transfer to other 
hospitals or lack of documentation.  
I therefore ended up including 133 children < 15 years of age that were admitted and treated 
for a febrile UTI during the study period (Table 5) 
 
Urine dipsticks results 
Table 6 shows that 130/133 (97.7%) were performed of which 113/133 (85.0%) were 
positive. For another view of the diagnostics, look to figure 3 for a flow-chart. 
 
Urine sampling method 
Table 7 shows that 50/125 (40.0%) of the samples was collected by mid-stream or clean 
catch, 48/125 (38.4%) were collected through bags, 17/125 (13.6%) were collected through 
single-use catheters. In 12/125 (9.6%) of the cases the method was not specified. For a  
Urine culture results 
125/133 patients (94.0%) urinary samples were cultured in total. A total of 112/125 (89.6%) 
samples were taken before administration of antibiotics, 10/125 (8.0%) after and in 3/125 
(2.4%) cases the timeline was not clearly documented. In 97/125 (72.9%) of the cultures were 
positive, 16/125 (12,8%) were probably contaminated and 12/125 (9.6%) showed no growth. 
Table 8 and Figure 2 show an overview of the culture results. Around 90% were Gram 
negative.  
 
Blood culture results 
Table 9 shows that 109/133 (83.5%) blood samples were taken for culturing, of which 11/109 
(10.1%) showed significant growth, and two were likely to be contaminated. One of the 
positive samples was one were Staphylococcus Epidermidis was found on the blood sample, 
while Klebsiella was found in the urine sample. If excluded, the bacteremia rates are 10/109 




Table 10 shows the different bacteraemia rates among gender and age groups. Male gender 
and low age was more commonly associated with  bacteraemia . 
 
Signs, symptoms and risk factors 
Table 11 shows an overview of the patients’ signs, symptoms and risk factors. The most 
common general symptom was poor condition 112/133 (84.2%) and feeding or difficulties 
89/133 (66.9%). The most common risk factors were renal abnormalities 48/133 (36.1%) and 
a previous UTI 40/133 (30.1%) 
 
Age differences 
The median age of the children was 1 year and the mean 3.25 years. The differences between 
the children <2 years of age and those ≥2 years of age can be seen in Table 12. Fever as the 
presenting symptom was more common among the younger children, whilst in older children 
micturition-associated symptoms and signs were more common. The older children carried 




The differences between the genders can be seen in Table 13. Several significant differences 
in symptoms were seen between the genders. However when adjusting for age differences 
however, no significant differences in symptoms were found between the genders. The only 
differing risk factors in general was bladder catheterization between the genders. However, 
for children under the age of two, foul-smelling urine was significantly more common in 
girls, whilst bladder and bowel dysfunction was more common in boys. For children of 2 
years of age or above, bladder and bowel dysfunction, bladder catheterization and VUR were 
more common in boys. 
 
E. coli vs non-E. coli 
The differences between E.coli and non-E.coli can be seen in table 14. Divided into groups of 
E.coli and non-E.coli, no significant differences were found in symptoms. VUR, other kidney 
abnormalities, bladder catheterization, bladder and bowels dysfunction and male gender was 
more commonly seen in cases with non-E.coli. 
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Divided by gender, amongst males previous UTI and VUR was more common in cases with 
non-E-coli. For females, bladder catheterization was more commonly seen in cases with a 
non-E.coli pathogen. 
 
C-reactive protein (CRP) 
Table 15 shows the differences between two dichotomized groups of CRP, showing 
significantly more nausea and or vomiting in the group with CRP ≥100 mg/L, no other 
general differences were found. 
Among children <2 years of age, nausea and/or vomit was significantly more common among 
those with CRP ≥ 100 mg/L. For children ≥ 2 years of age, CRP ≥100 mg/L was more 
common in those with no prior UTI and no known bladder or bowel disorder. 
 
Radiological investigations 
As table 5 shows, 51/117 (43.6%) ultrasounds were pathological. VUR was found in 15/133 
(11.3%) patients. In the group with pathological ultrasound, 13/51 (25.5%) suffered from 
VUR. An overview of all radiological examinations is presented in Table 16. Sixty-three 
children were considered at-risk by guidelines definition, as explained earlier in the paper. Of 
these, 47/63 (74.6%) had an ultrasound taken while admitted, 6/63 (9.5%) did not have any 
ultrasound performed. Twenty-five children <3 years were not at risk. 21/25 (84%) had an 
ultrasound performed while admitted and 1/25 (4%) after discharge. 
Twenty-five of 45 (55.6%) children ≥3 years of age had an ultrasound while admitted 
and 7/45 (15.6%) after discharge. In 8/45 (17.8%) children it was done previously. In 5/45 
(11.1%) cases it was never performed. 
MCUG is only indicated in children <3 years of age when defined as at-risk. Fifty-
eight children were considered “at risk” and of these 42/58 (72.4%), an MCUG was never 
performed. MCUG is also recommended if there is an abnormal ultrasound in children >3 
years of age. Of these 23 children, 15/23 (65.2%) never had an MCUG performed. 
In total, 110 ultrasounds and 18 MCUGs were performed. 
Table 17 shows that 33/133 (24.8%) children had several known recurrences of UTIs, 
20/33 (60.1%) had one known recurrence of UTIs and 80/133 (60.2%) had no known 
recurrences. Amongst the children with known renal or urological abnormalities 22/57 
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(38.6%) had several known recurrences of UTIs compared to 11/74 (14.9%) in the group with 
no known abnormalities (P<0.05) 
Of the children with known renal or urological abnormalities, 29/57 (50.9%) received 
prophylactic treatment through antibiotics or Hiprex, compared to 4/76 (5.3%) for those with 
no known abnormalities. In total 33/133 (24.8%) patients received prophylactic treatment.  
 
Antibiotic choice and duration 
Table 18 demonstrates the antibiotic agents used in the different treatment stages.  
The route of administration changed from 98/126 (77.8%) for initial antibiotic treatment to 
80/130 (61,5%) after blood and urine results were available. For 115/131 (87.8%) patients 
there was documentation about the treatment period at home. The mean home treatment 
period was 7.5 days. Mean total length of treatment was 10.5 days 
 
Antibiotic resistance data 
Table 19 shows the resistance pattern for E. coli isolates in comparison with NORM-data 
from 2015.  
Temperature 
The temperature taken at admission was dichotomized into below 40oC and 40oC and above, 
see table 20. T-test comparisons between the groups showed significant decrease in  
haemoglobin and sodium in temperatures ≥40oC. There was a slight increase in CRP and 
leucocytes when the temperature were ≥40oC, but not statistically significant 
 
CRP  
The maximal CRP recorded for each child was dichotomized into groups below 100 mg/L 
and from 100 mg/L and above, see Table 21. T-test comparisons between the groups showed 
an increase in leucocytes and maximal potassium, and a decrease in hemoglobin and minimal 
sodium with CRP-values ≥ 100mg/L. There also an association with rising creatinine levels 






The age differences and the gender distribution was as expected. Most children were young 
and the majority female. The females were on average older than the males, in line with the 
available literature (5). 
 
Urinary dip stick was performed in 97.7% of the cases, which indicates that most doctors are 
aware of the unspecific signs and symptoms of UTIs in children. Some where performed in an 
out-patient clinic before admission and several were repeated while admitted. 
Culturing was performed in 94% patients. In most cases (89.6%) the urinary sample was 
collected before antibiotics were administered, further indicating that Norwegian doctors are 
aware of the insidious nature of pyelonephritis and the importance of guided antibiotic 
treatment to lower the antibiotic resistance drive. 
 
Almost ¾ of the cultures showed significant growth. E.coli was the most commonly found 
pathogen with 74/97 (76.3%), followed by Klebsiella and Enterococcus spp. Unfortunately 
our data set was not big enough to fully represent the total pathogen frequency, but the rate 
between E. coli and non-E.coli can be discussed. For males, E. coli represented 18/31 (58.1%) 
of the culture results, whilst for females they constituted 56/66 (84.8%). This is similar to 
another study (26) where the numbers where 50% for males and 80% for females.  
 
The bacteraemia rates found in our study (10%) were higher than those found in a recent  
Israeli study at 5.6% (34). Moreover, for boys these rates in Israel were 10.9%, whilst ours 
were 18.9%. Although these children were both younger, and they were circumcised, skewing 
the results. We included one sample of Staphylococcus epidermidis in our results, were 
Klebsiella, which makes it a dubious result. Excluded, that leaves us with 9.2%. One study in 
adults found a bacteraemia prevalence of 15% in patients 16 years of age and older(35). A 
study in infants found a bacteraemia prevalence of 20% (15), similar to our findings of 13.6% 
in children <2 years of age. Overall the rates seem to differ greatly, but our numbers seem to 
fall somewhere in between. 
 
The most frequent signs and symptoms seen were reduced general condition 112/133 (84.2%) 
and difficulty in feeding or drinking (66.9%). This is expected for a child sick enough to be 
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admitted to a hospital. The single most frequent reason for contacting health services was 
fever, as seen in another study (15). The pre-verbal children have few signs and symptoms to 
express their discomfort, and fever is the most objective one measureable at home. The older 
children typically had several symptoms, as parents can then rely on a broader clinical picture 
before contacting health services. The signs and symptoms differed on the basis of age, 
gender, pathogens and CRP-values. 
 
Nausea and/or vomit, frequent and/or painful voiding was more commonly seen in female 
children than male, however it was not significant when adjusting for age. This suggests that 
these symptoms are age related, as they are seen more often in older children in general. 
Irritability was more common in male children, but adjusted for age it was not significant. 
These differences can be explained by the age difference between the genders, the males were 
younger than the females. None of the gender specific signs and symptoms showed 
significance when adjusting for age differences. This indicates that most of the reported 
symptoms were also largely age-related, rather than gender specific, however risk factors are 
more prevalent in male children than female. 
 
VUR was more commonly seen in patients with non-E.coli pathogens, a well-known 
mechanism for developing UTIs and non-E.coli. The link between non-E.coli pathogens and 
an underlying renal or urological abnormality has been shown before (36), although we 
couldn’t find any specific reasons as to why. Although we know children who have recently 
finished antibiotic treatment are at risk, and that urostasis provides an excellent medium for 
bacterial growth and that these abnormalities provide risk of both. 
 
The increased nausea and/or vomit rates seen in high CRP values in the younger age group 
could be explained by the general poor condition of the child (37). There were increased rates 
of high CRP values in children ≥ 2 years of age with no prior UTI or bladder and bowel 
disorder. One explanation for that parents and children in cases of recurring UTIs might be 
more aware of the symptoms, contacting the health services earlier, diagnosing the disease 
before it has evolved further. The increase in leucocytes with rising CRP-values could be 
explained by CRP’s role as an opsonizing agent in the immune response, where leucocytes 
play a vital part. The association to increased potassium and decreased levels of haemoglobin 
and sodium might be due to the fluid resuscitation given during the acute phase of the hospital 
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admission or potentially associated with slight renal affection of sorts due to the infection. It 
is however known that acute bacterial infection can cause anaemia in children(38). 
 
In around 40% of the children included the RBUS showed some kind of pathology, which 
was similar to some previous studies. However, when extracting these data, temporary 
ultrasound changes deemed “pyelonephritis like changes” were included. The degree of 
permanent scarring before or after the pyelonephritis is hard to quantify as there in many 
cases were neither prior, nor later ultrasounds to compare with. These results are similar to the 
results found in an Australian study(17) where they found a 56% prevalence of any 
radiological abnormality. These children were however younger than our children, and the 
rate of VUR much higher, 42% vs 11.3%. This could be explained by the more aggressive 
investigative measures taken, as well as the age difference. 
In children with known VUR, 13/15 yielded pathological ultrasounds. VUR is hard to 
diagnose with ultrasound alone, but this seems to indicate that ultrasound is a relatively 
sensitive tool for diagnosing VUR, having a sensitivity of 86.7%. MCUG, the gold-standard 
tool for diagnosing VUR, was only performed in 18 patients, meaning there is a chance that 
several children never got diagnosed with a low grade VUR. The prevalence of VUR was in 
one study estimated 17.2% in the normal population and 31.1% in children with VUR(39). 
The latter number does correlate well with the prevalence of VUR in our study amongst those 
who had an MCUG performed, 31.1% vs 33.3%. 
 
Ultrasound is indicated in every child with a first time febrile UTI. Amongst the children <3 
years of age, the guidelines were followed in 47/63 children at-risk, and in 22/25 children not 
at risk. In total, 9/88 (10.2%) children under 3 years of age never received an ultrasound scan. 
Amongst the children 3 years of age the results were slightly different, as it recommends that 
there be taken one after a febrile UTI. In 40/45 (88.9%) of the cases the guidelines were 
followed. These numbers can be improved upon, although many children only stayed at the 
hospital for a few days and therefore had to take the ultrasound as a policlinic patient later. 
Ultrasound is however a quick and easy examination and could yield treatment altering 
information. MCUG was only performed in 18 children. In children under two years of age, 
the guidelines were only followed in 16/58 (27.6%) of the children. Amongst children above 




Recurrences were more common in children with renal or urological abnormalities, further 
stressing the importance of diagnosing these children. Out of the 22 children these 
abnormalities and several UTI recurrences, 13 received prophylactic treatment compared to 1 
in 11 without these risk factors. Identifying these children could be important and yield 
therapeutic intervention. Increasing the amount of MCUGs performed in children deemed at-
risk could potentially result in more targeted prophylactic treatment.  
The results show that more than 90% of  initial antibiotic treatments was in line with 
Norwegian empirical regime standards (1). Almost half of the patients were still receiving 
ampicillin and gentamicin in IV-form after some test results were available. In some cases the 
culture was negative or showed likely contamination, yielding no viable resistance patterns to 
guide the treatment. In other cases the antibiotic treatment was continued due to clinical 
progression where the child was seen as too sick to receive oral antibiotics. 
The prescription of amoxicillin-clavulanic acid as part of home treatment was widespread. 
This shows that hospital culture in many cases determine treatment.  
 
The antibiotics resistance pattern of the E. coli cultures overlapped well with the data 
collected from NORM. As previously stated, the intermediary resistant were classified as 
sensitive, which was done for the NORM-table as well to get more representative numbers. 
Only slight differences were found, probably related to the relatively small data. The NORM 
data also only represents one year of data collection, whilst ours represents 10 different years 
where the resistance rates vary. 
 
Limitations of the study 
This thesis has many limitations that are inherent with retrospective studies. The author opted 
to include a large number of variables. Some of these variable/data were missing or difficult 
to retrieve and some were probably missed or mislabelled due to inexperience. 
Inadequate response to treatment within 48 hours, hydronephrosis on prenatal ultrasound and 
elevated blood pressure were not included in the risk group stratification analyses as the data 
was not extracted and hence not present in the data set.   
When searching for symptoms, the wording was slightly different for each patient and many 
times the words came from the general practitioners, from which many children were directed 
to the hospital. 
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Risk factors were hard to detect, especially since many doctors never asked and the patients’ 
never informed them. Some were even gathered from reviewing journals of their siblings due 
to matching surnames, creating a substantial amount of detective work. 
When missing, signs, symptoms and risk factors were treated as not present during the 
statistical analyses.  
Some blood values were hard to make representative as some were ordered at different 
timings, but most were extracted from the same blood set. 
In regards to the home treatment, we cannot tell for sure how long they were actually taken, 
just the dosage prescribed. Therefore the length of antibiotic treatment was set at hospital 
treatment start for all patients. 
Urinary results varied for each patient was not always documented and sometimes had to be 
extracted from texts or referrals from the outpatient clinics. Another weakness with the study 
comes from the lab-reports, as the sampling method was often labelled “mid-stream urine”, 
although that is the standard  
Not every risk factor for ultrasound and MCUG indication could be applied to the risk-
stratification as some data necessary were never collected. This possibly left some at-risk 
children out of the pool, not representing the entire truth. However, pyelonephritis-likely 
changes were also categorized as pathological as labelled by the radiologists. 




This study has shown that the gender and age distribution was in accordance to available 
literature. It has also shown that doctors at UNN and the outpatient clinics in Tromsø, Narvik 
and Harstad are highly aware of urinary tract infections as a differential diagnosis, performing 
dipstick analyses in 97.7% and culturing the urine in 94.0% of the cases, in which the sample 
was clearly collected before the administration of antibiotics in 89.6%. 
The signs, symptoms and risk factors differed significantly (P<0.05) based on the factors of 
age, gender, pathogens and CRP-values. The differences in signs and symptoms were mostly 
age related, probably related to the child’s ability to report their discomfort. Risk factors were 
associated with higher age, male gender, non-E.coli and higher CRP-values. Although in 
CRP-values, a lower incidence of risk factors were seen in children with higher CRP-values. 
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This was probably related to patient information, and urgent hospital visits when signs and 
symptoms of UTI presented themselves. 
There were 72.9% cases of significant bacteruria and 10.2% cases of significant bacteremia. 
E.coli was the most prevalent pathogen found, both in urine and blood culture. It represented 
76.3 % of urine isolates and 63.6% of the blood cultures with significant growth. The second 
most prevalent bacteria was Klebsiella, constituting 8.2% of urine and 18.2% of blood 
cultures. 
Ultrasound was performed in 110 patients and MCUG in only 18. Abnormal genitourinal 
findings had a prevalence of 57/133 (42.9%), and VUR was found in 15/133 (11.3%). This 
was a lower prevalence of VUR than expected from literature, but it was diagnosed in 6/18 
(33.3%) MCUGs performed. This indicates that the prevalence might be higher than that 
found in this study. 
Antibiotics were given to 131/133 (98.5%) of the patients, of which empirical treatment 
followed Norwegian guideline standards in 114/126 (90.5%) of the cases. Ampicillin-
Gentamicin IV was the most commonly used antibiotic in both the empirical (85.7%) and 
during the admission (47.7%). Amoxicillin-clavulanic acid was the most used antibiotic 
during the home treatment phase (45.7%), even being used in 3/33 cases were it was resistant. 
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Table 1: Escherichia coli in urine (29) 
    
 Breakpoints (mg/L)  Proportion of isolates (%) 
       
       
 Susceptible Resistant  Susceptible Intermediately 
susceptible 
Resistant 
Ampicillin ≤ 8 > 8  65.9 - 34.1 
Mecillinam ≤ 8 > 8  94.9 - 5.1 
Amoxicillin-clavulanic acid* ≤ 32 > 32  93.9 - 6.1 
Cefuroxime ≤ 8 > 8  95.6 - 4.4 
Cefotaxime ≤ 1 > 2  96.7 0.1 3.2 
Ceftazidime ≤ 1 > 4  96.5 1.0 2.5 
Meropenem ≤ 2 > 8  99.9 0.1 0.0 
Gentamicin ≤ 2 > 4  96.2 0.4 3.4 
Ciprofloxacin ≤ 0.5 > 1  92.4 0.3 7.3 
Nitrofurantoin ≤ 64 > 64  99.0 - 1.0 
Trimethoprim ≤ 2 > 4  76.9 0.1 23.0 
Trimethoprim-sulfamethoxazole** ≤ 2 > 4  78.4 1.1 20.5 





Table 2: Klebsiella spp. in urine (29) 
    
 Breakpoints (mg/L)  Proportion of isolates (%) 
       
       
 Susceptible Resistant  Susceptible Intermediately 
susceptible 
Resistant 
Mecillinam ≤ 8 > 8  89.0 - 11.0 
Amoxicillin-clavulanic acid* ≤ 32 > 32  93.6 - 6.4 
Piperacillin-tazobactam ≤ 8 > 16  89.7 6.3 4.0 
Cefuroxime ≤ 8 > 8  91.6 - 8.4 
Cefotaxime ≤ 1 > 2  96.3 0.4 3.3 
Ceftazidime ≤ 1 > 4  94.1 2.3 3.6 
Meropenem ≤ 2 > 8  100.0 0.0 0.0 
Gentamicin ≤ 2 > 4  97.2 0.5 2.3 
Ciprofloxacin ≤ 0.5 > 1  94.3 2.2 3.5 
Trimethoprim ≤ 2 > 4  79.9 1.7 18.4 
Trimethoprim-sulfamethoxazole** ≤ 2 > 4  84.8 1.7 13.5 





Table 3: Enterococcus spp. in urine (29) 
    
 Breakpoints (mg/L)  Proportion of isolates (%) 
       
       
 Susceptible Resistant  Susceptible Intermediately 
susceptible 
Resistant 
Ampicillin ≤ 4 > 8  94.4 0.2 5.4 
Gentamicin* ≤ 128 > 128  - 84.2 15.8 
Linezolid ≤ 4 > 4  100.0 - 0.0 
Trimethoprim* ≤ 0.032 > 1  0.0 79.0 21.0 
Trimethoprim-sulfamethoxazole*/** ≤ 0.032 > 1  0.0 85.0 15.0 
Vancomycin (any genotype) ≤ 4 > 4  100.0 - 0.0 





Table 4: A complete list of all variables 
Age The age of the child at the admission 
Gender Male or female 
Temperature  
- Temperature maximum before or after 
24 hours of admission 
Recorded in Celsius, either from an out-of-
hospital setting or while admitted 
- Temperature at admission Recorded temperature at admission in Celsius 
Signs and symptoms: Here we recorded the following signs and 
symptoms from either the patients at admission 
or reports from the outpatient clinic: Answered 
yes or no 
- Reported pain in the back or the 
abdomen of the child 
 
- Nausea and/or vomit  
- Diarrhoea or loose stools  
- Irritability  
- Poor general condition  
- Painful and/or frequent urination  
- Poor condition  
- Jaundice  
- Foul-smelling urine  
- Tenderness in the abdomen or back As observed by the clinician 
Risk factors Here we recorded the following risk factors 
from either the patients at admission, reports 
from the outpatient clinic or hospital data: 
Answered yes or no 
- Previous UTI Any previous UTI, both cystitis and 
pyelonephritis was included 
- Bladder and bowel dysfunction Includes diaper-needing patients, from CP and 
other neurological disorders, chronic obstipation 
and other gastrointestinal disorders, and those 
with any functional urinary problems. 
- Family history of UTI  




- VUR Any grade was included. The timing of the 
diagnosis was not documented 
- Any other renal abnormality Lists all known renal abnormality known 
previously or diagnosed by a radiologist 
Urine dipsticks  
- Leucocytes Negative, traces or + to 4+ 
- Erythrocytes Negative, traces or + to 4+ 
- Nitrite Negative, traces or positive 
Urine culturing  
- Timing Before or after the administration of antibiotics 
- Sampling method Recorded the method used for collecting the 
sample, categorized into: Bag, catheter, 
suprapubic catheter, clean catch/mid stream and 
no information 
- Results The culture result was categorized into 
significant growth, likely contaminated and no 
growth.  Each pathogen was recorded. 
Ultrasound  
- Timing While admitted, after admission or not 
performed during this episode 
- Results The results were gathered from the radiologist’s 
description, and labelled as such. Catergorized 
into pathological or normal 
MCUG  
- Timing While admitted, after admission or not 
performed during this episode 
- Results The results were gathered from the radiologist’s 
description, and labelled as such. Catergorized 
into pathological or normal 
Blood values Each patient’s most extreme blood values were 
gathered, taken from one single blood sample 
when possible 
- CRP (C-reactive Protein) Highest recorded value during admission 
- Leucocytes Highest recorded value during admission 
- Haemoglobin Lowest recorded value during admission 
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- Thrombocytes  Lowest recorded value during admission 
- Creatinine Highest recorded value during admission 
- Sodium (Na+) Lowest recorded value during admission 
- Potassium (K+) Highest recorded value during admission 
Blood culturing  
Results The culture result was categorized into 
significant growth, likely contaminated and no 
growth.  Each pathogen was recorded. 
Antibiotic resistance patterns The resistance pattern for each pathogen was 
recorded, intermediary resistance was plotted as 
susceptible.  
Antibiotics  
- Type of antibiotics Each antibiotic used was recorded for three 
phases: Empirical treatment, after culture or 
blood results and home treatment 
- Route of administration Categorized into intravenous (IV), per oris (PO) 
or not specified. 
- Treatment days Both hospital treatment days and home 
treatment was recorded 
Admission length Recorded in days 
Recurrency of UTI Did not distinguish between cystitis and 
pyelonephritis 
Prophylaxis Hiprex or antibiotics, either using before or 






Table 5: Descriptive overview of the patients 
 
Variable N % Mean (SD) Median (IQR) 
Patients 133 100%   
Age (in years)   3.3  (4.5) 1 (0.25-4.5) 
- Females  91 68.4% 3.8 (4.5) 1.8 (0.6-5.5) 
- Males 42 31.6% 2.1 (4.2) 0.3 (0.2-0.9) 
Temperature at admission   38,7 (1.1)  
Positive urine culture 97 72.9%   
Admitted (days)   3.0 (2.1) 3.0 
Pathological ultrasound 51 43.6%   
Known VUR 15 11.3%   





Table 6: Descriptive table of urine dipsticks results 
Leucocytes Frequency Percent 
 
0 7 5.4% 
+ 9 6.9% 
2+ 23 17.7% 
3+ 46 35.4% 
4+ 44 33.8% 
Traces 1 0.8% 
Total 130 100% 
Nitrite Frequency Percent 
 
Negative 65 50% 
Positive 58 44.6% 
Missing data 6 4.6% 
Traces 1 0.8% 
Total 130 100% 
Erythocytes Frequency Percent 
 
Neg 14 10.8% 
Traces 11 8.5% 
1+ 16 12.3% 
2+ 31 23.8% 
3+ 31 23.8% 
4+ 17 13.1% 
Missing data 8 6.2% 






Table 7: Urine sampling methods 
 
Urine sampling N % 
Urinary sampling before or after antibiotics: 
- Before 
- After 












- Clean catch 















Table 8: Pathogen overview from urine cultures 
 
 N % 
Samples 
- Significant growth 
- Likely contamination 
- Negative 











Pathogen N % 
E.coli 74 76.3% 
Klebsiella 8 8.2% 
Enterococcus 6 6.2% 
Two or more pathogens 3 3.1% 
Enterobacter 2 2.1% 
Staph. aureus 1 1.0% 
Staph. saprophyticus 1 1.0% 
Pseudomonas aeruginosa 1 1.0% 
Fungus 1 1.0% 






Table 9: Blood culture results 
 
Variables n % 
Samples 
- Negative 
- Significant growth 
- Likely contamination 











Pathogen detected in blood culture: 
- E. coli 
- Klebsiella 
- Enterococcus 
















Chi-square analysis of the differences in bacteremia rates in gender and age. 












Age <2 years of age 
≥2 years of age 










Table 11: Signs, symptoms and risk factors of the 133 patients: 
Signs and symptoms n % 
Reduced general condition 112 84.2% 
Feeding or drinking difficulties 89 66.9% 
Nausea and/or vomiting 65 48.9% 
Irritability 54 40.6% 
Tenderness in the abdomen or back 48 36.1% 
Pain in the abdomen or back 47 35.3% 
Foul smelling urine 29 21.8% 
Frequent and/or painful micturation 27 20.3% 
Diarrhoea and/or loose stools 18 13.5% 







Other renal abnormalities 48 36.1% 
Previous UTI 40 30.1% 
Bladder and bowel dysfunction 27 20.3% 
VUR 15 11.3% 
Positive family history 14 10.5% 






Table 12: Analysis by age groups 
 
Variable Age < 2 years 
N=82 
Age ≥  2 years 
N=51 
P-value 
Reported pain 12 (14.6%) 35 (68%)  < 0.001 
Nausea / Vomit 30 (36.5%) 35 (68%) < 0.001 
Diarrhoea / 
loose stools 
14 (17.1%) 4 (7.8%) 0.13 
Frequent / painful micturation 2 (2%) 25 (49.0%) < 0.001 
Irritability 48 (58.5%) 6 (11.8%) < 0.001 
Jaundice 1 (1.2%) 0 0.43 
Poor condition 67 (81.7%) 45 (88.2%) 0.315 
Poor feeding 56 (68.3%) 33 (66.7%) 0.669 
Foul-smelling urine 19 (23.2%) 10 (19.6%) 0.628 
Tender abdomen/back 14 (17.1%) 34 (65.4%) 0.000 
Previous UTI 7 (8.5%) 33 (64.7%) 0.000 
Other renal abnormality 26 (31.7%) 22 (43.1%) 0.182 
Positive family history 9 (11.0%) 5 (9.8%) 0.830 
Bladder catheter 3 (3.8%) 2 (3.9%) 0.938 
Bladder and bowel dysfunction 9 (11.0%) 18 (35.3%) 0.001 












Reported pain 36 (39.6%) 11 (25%) 0.134 
Nausea /Vomit 50 (54.9%) 15 (35.7%) 0.039 
Diarrhoea /loose stools 13 (14.3%) 5 (11.4%) 0.709 
Frequent /painful micturation 23 (25.3%) 4 (9.5%) 0.036 
Irritability 31 (34.1%) 23 (52.3%) 0.024 
Jaundice 1 (1.1%) 0 0.495 
Poor condition 78 (85.7%) 34 (77.3%) 0.484 
Poor feeding 65 (71.4%) 24 (54.5%) 0.104 
Foul-smelling urine 25 (27.5%) 4 (9.5%) 0.628 
Tender abdomen/back 37 (40.7%) 11 (25%) 0.106 
Previous UTI 31 (34.1%) 9 (20.5%) 0.140 
Other renal abnormality 30 (33.0%) 18 (40.9%) 0.270 
Positive family history 7 (7.7%) 7 0.117 
Bladder catheter 1 (1.1%) 4 (9.5%) 0.018 
Bladder and bowel dysfunction 15 (16.5%) 12 (27.3%) 0.107 






Table 14: Analysis by pathogens: 





Reported pain Yes 27 (36.5%) 8 (34.8%) 0.882 
Nausea / Vomit Yes 38 (51.4%) 12 (52.2%) 0.945 
Diarrhoea / loose stools Yes 10 (13.5%) 4 (17.4%) 0.644 
Frequent /painful micturation Yes 17 (23.0%) 3 (13.0%) 0.304 
Irritability Yes 29 (39.2%) 11 (47.8%) 0.462 
Jaundice Yes 1 (1.4%) 0 0.575 
Poor condition Yes 64 (86.5%) 18 (78.3%) 0.341 
Poor feeding Yes 51 (68.9%) 13 (56.5%) 0.273 
Foul-smelling urine Yes 21 (28.4%) 2 (8.7%) 0.053 
Tender abdomen and/or back Yes 31 (41.9%) 6 (26.1%) 0.173 
VUR Yes 5 (6.8%) 7 (30.4%) 0.003 
Other kidney abnormality Yes 23 (31.1%) 14 (60.9%) 0.010 
Previous UTI Yes 23 (31.1%) 10 (43.5%) 0.273 
Positive family history Yes 11 (14.9%) 1 (4.3%) 0.181 
Bladder catheterization Yes 1 (1.4%) 3 (13.0%) 0.014 
Bladder and bowels 
abnormalities 
Yes 12 (16.2%) 9 (39.1%) 0.020 
Age Above 2 
years 
30 (41%) 8 (34.8%) 0.621 
Gender Male 18 (24.3%) 14 (60.9%) 0.004 





Table 15: Analysis by CRP-values 
Variable CRP < 100 mg/L 
N= 55 
CRP ≥ 100 mg/L 
N=77 
P-value 
Reported pain 15 (27.3%) 32 (41.6%) 0.091 
Nausea / Vomit 18 (32.7%) 47 (61.0%) 0.001 
Diarrhoea / 
loose stools 
7 (12.7%) 11 (14.3%) 0.797 
Frequent /painful micturation 7 (12.7%) 20 (26.0%) 0.063 
Irritability 22 (40.0%) 32 (41.6%) 0.858 
Jaundice 1 (1.8%) 0 0.235 
Poor condition 44 (80.0%) 67 (87.0%) 0.277 
Poor feeding 32 (58.2%) 57 (74.0%) 0.056 
Foul-smelling urine 10 (18.2%) 19 (24.7%) 0.374 
Tender abdomen/back 15 (27.3%) 32 (41.6%) 0.091 
VUR 4 (7.3%) 11 (14.3%) 0.211 
Other kidney abnormality 18 (32.7%) 29 (37.7%) 0.559 
Previous UTI 14 (25.5%) 21 (27.3%) 0.384 
Positive family history 5 (9.1%) 9 (11.7%) 0.633 
Bladder catheterization 1 (1.8%) 4 (5.2%) 0.316 


















Table 16: Imaging modalities used 
Radiological examination: N % 
Ultrasound <3 years months at risk: 
 While admitted: 
 After discharge: 
 Done previously   











Ultrasound <3 years months not at risk: 
 While admitted: 
 After discharge: 
 Done previously   











Ultrasound >3 years: 
 While admitted: 
 After discharge: 
 Done previously: 











MCUG <3 years at-risk: 
 While admitted: 
 After discharge: 
 Done previously: 











MCUG>3 years with abnormal ultrasound: 
 While admitted: 
 After discharge: 
 Done previously: 















Table 17: Association between renal abnormalities, recurring UTIs and 
prophylaxis  
 
Variable  Normal findings 
N=76 






















  Normal findings 
and several known 
recurrences of UTI 
N=11 
Renal or urological 
abnormality and several 
























Table 18: Antibiotic use  
 
Variable N % 
Antibiotics 131 98.5 % 



















































Variable  N % 
Antibiotics after test results: 
Ampi-Genta IV 









































Variable N % 




































Treatment length Mean Median 
Antbiotic home treatment (days) 7.5 7 





Table 19: Resistance pattern for E. coli – This study versus NORM 2015. 
 




This study  
Resistance rate in 
NORM (year) 
Amoxiclav 68 5.9% 6.1% 
Ampicillin 73 28.4% 34.1% 
Cefotaxime 70 1.4% 3.2% 
Cefuroxime 70 2.9% 4.4% 
Ciprofloxacin 72 2.8% 7.3% 
Gentamicin 69 1.4% 3.4% 
Mecillinam 72 4.2% 5.1% 
Meropenem 69 0% 0% 
Nitrofurantoin 74 0% 1% 
Trimethoprim 72 22.2% 23.0% 
Trimethoprim-
sulfamethoxazole 





Table 20: Temperature below or above 40 oC   
 
Variable Temp. N Mean SD P-value 













































































Table 21: Variables compared to CRP below or above 100 mg/L 









































































Documentation level  II 
Grade:  C 
Objective Material og method Results Discussion 
To report the total 
spectrum of 
presenting symptoms 
and the incidence of 
renal tract 
abnormalities during 
the newborn period. 
From the opening of the Mercy Maternity 
hospital until December 1974, particular 
attention was given to the diagnosis of 
urinary infection in newborn infants. 
Suprapubic bladder puncture (Pryles et al., 
1959) was performed in all infants 
presenting with jaundice of unknown 
aetiology, failure to gain weight, excessive 
weight loss, diarrhoea, vomiting, or a 
clinical picture of sepsis. A diagnosis of 
infection was accepted if there was any 
bacterial growth from the urine obtained 
by this method, and all such infants 
received a course of parenterally 
administered antibiotics. After 7 days of 
treatment they were subjected to 
intravenous pyelography and micturating 
cystourethrography. At the time of 
performing the cystourethrogram, urine 
was collected via the catheter and cultured; 
in only 2 infants was there still a 
significant growth of organisms. 
Selective suprapubic urine aspiration was 
performed in 905 infants; 64 were found to have 
urinary infection, representing 0.5% of all live-
births over the 47 months of the study 
54 (84%) were males and 10 (16%) were 
females. 14 (22%) were born before 37 weeks of 
gestation and 50 (78%) were term infants. Mean 
day of age at presentation was day 10 for term 
infants and 18 for preterms. Mean length of stay 
of infants in the hospital was 10.6 days; 33 % 
remain 10 or more days. 
Thirty (56%) of the 54 male infants and 5 of the 
10 female infants were found to have a 
radiological abnormality (Table II). 
In 27 infants vesicoureteric reflux was the only 
abnormality present. The vesicoureteric reflux 
was bilateral in 14 and unilateral in 13 infants. 6 
infants were found with hydronephrosis; 3 with 
obstruction and 3 with megasystems associated 
with gross reflux. 
In the 3 infants in whom hydronephrosis was 
associated with megasystems and reflux, the 
diagnosis was initially suspected on the 
pyelogram and subsequently proven on the 
cystourethrogram. The megasystems were each 
unilateral. 
The groups were recruited from the same 
ewborn infants, although no background 
factors were adjusted for. 
The group is partly representative for the, 
although they were selected due to 
presenting reminiscent UTI-symptoms, 
narrowing the study population. 
The study was a prospective cohort study 
with sufficient follow-uptime to document the 
UTIs they were studying 
No drop-outs were discussed, except the 
children who died 
The exposition and outcome was measured 
using objective criteria with standardized 
procedures. 
The people who reviewed the results were 
not blinded, nor were any confounders 
identified. 
 
The study was a big prospective study 
including a lot of highly detailed radilogogical  
A weakness of the study is the fact that no 
limitations were discussed, and that no 
statistical analyses were performed. 
 
Conclusion 
Because of this high 
incidence of 
abnormalities, which 
when diagnosed might 




performed in newborn 




Year of data collection 




Referanse:       Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract 
infections. The Journal of urology. 2013;190(1):222-7. 
 
Design: Case series 
Documentation level:  III 
Grade:  B 
Objective Material and method Results Discussion 
To characterize the current national 
patterns of antibiotic resistance of 
outpatient pediatric urinary tract 
infection. 
Outpatient urinary isolates from 
patients younger than 18 years 
in 2009 were examined using 
The Surveillance Network®, a 
database with antibiotic 
susceptibility results and patient 
demographic data from 195 
United States hospitals.  
The prevalence and antibiotic 
resistance patterns for the 6 
most common uropathogens, ie 
Escherichia coli, Proteus 
mirabilis, Klebsiella, 
Enterobacter, Pseudomonas 
aeruginosa and Enterococcus 
was determined. Differences in 
uropathogen prevalence 
between males and females 
using chi-square analysis were 
compared 
E. coli was the most common 
uropathogen overall but the prevalence of 
E. coli was higher among females (83%) 
than males (50%, p <0.001).  
 
Other common species among males 
were Enterococcus (17%), P. mirabilis 
(11%) and Klebsiella (10%). However, 
these uropathogens each accounted for 
5% or less of female isolates (p <0.001). 
 
Resistance among E. coli was highest for 
trimethoprim-sulfamethoxazole (24%) but 
lower for nitrofurantoin (less than 1%) and 
cephalothin (15%).  
 
E. coli resistance rates increased for 
trimethoprim-sulfamethoxazole (from 23% 
to 31% in males and from 20% to 23% in 
females) and ciprofloxacin (from 1% to 
10% and from 0.6% to 4%, respectively). 
The data came from a selected 
patient group, but  was relevant for 
the disease. It is however more 
relevant to its geographical area 
due to the nature of antibiotic 
resistance drive. 
 
The inclusion criteria were clearly 
defined, but no follow-up was made. 
 
All the data was collected through 
labs, so the yield was high. 
 
The study goes well into detail 
about its limitations, and how it 
compares to other studies. 
 
Even though it is a retrospective 
study, it follows clearly objective 
criteria and has a lot of data. 
Conclusion 
E. coli remains the most common 
pediatric uropathogen. Although 
widely used, trimethoprim-
sulfamethoxazole is a poor empirical 
choice for pediatric urinary tract 
infections in many areas due to high 
resistance rates. First-generation 
cephalosporins and nitrofurantoin 
are appropriate narrow-spectrum 
alternatives given their low 
resistance rates. Local antibiograms 
should be used to assist with 









Referanse:       Maherzi M, Guignard JP, Torrado A. Urinary tract infection in high-risk newborn infants. Pediatrics. 
1978;62(4):521-3. 
 
Design: Cohort study 
Documentation level:  II 
Grade:  C 
Objective Material og methods Results Discussion 
To define the 
characteristics of UTI in 
high-risk neonates and to 
decide if systematic 
screening for bacteriunia is 
justified in this population. 
1935 newborn infants were admitted to the 
neonatal intensive care unit of Lausanne, 
Switzerland, during four consecutive 
years.  Cestational age was assessed 
according to the method of Dubowitz and 
associates. Neonates were classified as 
follows, according to gestational age: 
premature, less than 259 days; term, 259 
to 293 days; postterm, more than 293 
days. Urine cultures were performed when 
symptoms were suggestive of UTI or at 
the end of the stay in the unit in 
asymptomatic patients. Urine was always 
obtained under sterile conditions, using 
standard methods. 
Any colony growth from urine obtained 
by suprapubic aspiration was considered 
to be mdicative of significant bacteriunia. 
Intravenous pyelography (IVP) and 
micturating cystourethrography (MCU) 
were carried out whenever possible on all 
patients with symptomatic UTI. 
Cystourethrography was performed after 
the urine had been sterilized by 
appropriate treatment. 
The prevalence of neonatal urinary tract infection 
(UTI) was studied in 1,762 high-risk neonates. 
 
There were 1,006 boys and 756 girls. Age on admission 
to the unit was up to 28 days. A urine culture was 
performed in 1,762 of them 
 
Symptomatic bacteriuria was found in 1.9% and 
asymptomatic bacteriuria in 0.5% of these neonates. 
  
Male preponderance was 5: 1 . 
 
Clinical manifestations were extremely vanable-
vomiting, weight loss, and diarrhea being the 
prominent symptoms.  
 
Bacteremia was associated with UTI in six infants.  
 
The organisms identified in the urine obtained by 
suprapubic aspiration were Escherichia co/i, Klebsiella, 
and Proteus. 
 
A mixed infection was found in four patients.  
 
Roentgenographic examination of the urinary tract 
showed abnormalities in 44% of the symptomatic 
patients. 
 
The groups were recruited from the 
same high-risk newborn infants, 
although no background factors were 
adjusted for. 
The group is partly representative for the 
initial risk group, although they were 
then selected for UTI-symptoms, further 
narrowing the study population. 
The study was a prospective cohort 
study with sufficient follow-uptime to 
document the UTIs they were studying 
No drop-outs were discussed, except 
the children who died. 
The exposition and outcome was 
measured using objective criteria with 
standardized procedures. 
The people who reviewed the results 
were not blinded, nor were any 
confounders identified. 
 
The strength of study is the sheer 
number of patients studied 
prospectively. The limits of the study is 
the limited discussion and the limited 
statistical analyses it provides. 
Conclusion 
That symptomatic high-
risk newborn infants 
should be screened for 
bacteniuria, and that 
radiological 
investigations be 
performed in those with 
proven infection. 
Pediatrics 62:521-52.3, 













Reference:       Martinell J, Lidin-Janson G, Jagenburg R, Sivertsson R, Claesson I, Jodal U. Girls prone to urinary infections 
followed into adulthood. Indices of renal disease. Pediatric nephrology (Berlin, Germany). 1996;10(2):139-42. 
Design: Cohort control 
Documentation level II 
Grade:  C 
Objective Material and method Results Discussion 
To study the link 
between pyelonephritis 
and kidney disease 
111 women recruited from their first 
UTI episode in childhood.  
 
They were selected because of a 
clinical risk of complications that at 
the age of 15-18 years led to 
referral to an adult unit for continued 
follow-up. The main indications for 
referral were renal scarring in 54 
and predisposition to UTI in 57; 36 
of those with renal scarring had a 
predisposition to UTI. 
Controls were recruited from 
females who had participated in a 
school screening program for 
bacteriuria performed between 1971 
and 1974. 
Each child was examined for blood 
pressure, creatinine and. albumin. 
β2-Microglobuli in urine and serum  
Renal scarring was defined as 
parenchymal reduction with 
clubbing of the adjacent calyx 
Voiding cystourethrography was 
performed using a standard 
technique and reflux graded on a 
five-grade scale 
The diastolic blood pressure was higher in females with 
severely scarred kidneys than controls (P<0.05). 
The glomemlar filtration rate was lower in women with 
severe renal scarring than controls (P < 0.005), while 
there was no difference between those with moderate 
scarring and controls. 
In females with severe scarring, 4 of 19 had a glomerular 
filtration rate below the lower reference limit ( < 80 
ml/min per 1.73 m2), but the filtration was only 
moderately decreased to between 70 and 78 ml/min per 
1.73m 2 
The glomerular filtration rate correlated with the total 
renal area (P<0.001). The total renal area was 
significantly smaller in women with severe as well as 
moderate scarring, compared with those without scarring 
(P<0.01) 
Creatinine concentrations in serum were higher for 
women with severe scarring than controls (P<0.05) 
β2-Microglobulin in serum was higher in women with 
severe scarring than controls (P < 0.05); the 
corresponding value for women with moderate scarring 
was P = 0.05. 
The excretion of  β2-microglobulin in urine was higher in 
women with severe renal scarfing than controls (P < 0.05) 
the corresponding value for moderate scarring compared 
with controls was P = 0.05 
No background factors were accounted for 
The girls recruited in this study came from 
the same population, and were selected 
due to+++ 
 
The controls are from the same age 
demographic as the study population and 
should carry the same exposure. 
 
The study was prospective, following the 
girls regularly by the same two clinicians, 
examined over a 3 year period 
 
There is no mentioning of drop outs from 
the study, only the ones included 
 
There was no mentioning of confounders in 
the study or any other forms of limations. 
 
The follow-up-time was 15 years, which is 
not enough time to fully see the effects of 
renal damage, as it usually targets the 
elderly. These patietnts were young on 
average. 
 
The study was not blinded.  
Conclusion 
That renal function 
was well preserved in 
most cases of renal 
scarring in girls with 







Reference:       Ginsburg CM, McCracken GH, Jr. Urinary tract infections in young infants. Pediatrics. 1982;69(4):409-12. 
 




Grade:  C 
Objective Material og method Results Discussion 
To show the clinical 
presentation of urinary 
tract infections in infants 
From  March 1976 
through February 1981, 
100 infants with acute 
urinary tract infections 
were admitted to the 
hospital from the acute 
care clinic of Children’s 
Medical Center or from 
the emergency room of 
Parkland Memorial 
Hospital, Dallas. 
Male infants accounted for the majority of urinary infections in the 
first three months of life, but female infants predominated thereafter. 
 
Only 5% of male infants in this study were circumcised 
 
There was no correlation between fever, the initial WBC count, or 
presence of roentgenographic abnormalities and a positive blood 
culture. A lumbar puncture was performed in 88 patients and all CSF 
cultures were sterile. 
 
Sepsis was documented in 20 of 91 infants from whom blood cultures 
were obtained. Approximately 85% of these positive blood cultures 
were in infants less than 2 months of age and only one of 18 infants 
aged more than 3 months had sepsis. 
 
Absence of significant pyuria did not rule out urinary tract infection. 
Less than 10 and 5 WBCs/HPF were found in 27% and 21% of urine 
samples, respectively. Bacteria were present on stained smears of 
most of these specimens and this proved the most reliable initial 
mdicator of infection. 
 
Roentgenographic abnormalities were present in 18% of patients, 78% 
of whom were girls. The incidence of radiographic abnormalities in 
the girls in this study was relatively large (45%) and significantly 
greater than that (7%) in boys. 
 
All infants responded promptly to antimicrobial therapy. 
The sole inclusion criteria was 
admission for UTI during 
infancy at the  
 
There was no mentioning of 
confounders in the study, but it 
does mention its limits as a 
retrospective study. 
 
The diagnose were validated 
through urine culture, although 
4 patients in this study did not 
have any significant growth 
and were not mentioned. 
 
The follow-up-time was 
sufficient to highlight the end 
points, which were to show the 
acute presentation of a disease 
Conclusion 
The data do 
emphasize the 
importance of 
obtaining urine and 
blood cultures on all 
young, febrile infants 
with suspected UTI. 
Country 
USA 
Year of data collection 
1976-1981 
 
